GLI1 and non-small cell lung carcinoma: Median PFS was shorter in Gli1+ NSCLC compared to Gli1- NSCLC: 1.9 months (IQR 1.2–5.7) vs. 6.1 months (1.6–26.0), respectively (p = 0.08) (Figure 2A).